SK3

SK3 (small conductance calcium-activated potassium channel 3) also known as KCa2.3 is a is_associated_with::protein that in humans is encoded by the KCNN3 is_associated_with::gene.

SK3 is a small-conductance is_associated_with::calcium-activated potassium channel partly responsible for the is_associated_with::calcium-dependent after hyperpolarisation current (IAHP). It belongs to a family of channels known as small-conductance potassium channels, which consists of three members – SK1, SK2 and SK3 (encoded by the KCNN1, 2 and 3 genes respectively), which share a 60-70% is_associated_with::sequence identity. These channels have acquired a number of alternative names, however a NC-is_associated_with::IUPHAR has recently achieved consensus on the best names, KCa2.1 (SK1), KCa2.2 (SK2) and KCa2.3 (SK3). Small conductance channels are responsible for the medium and possibly the slow components of the IAHP.

Structure
KCa2.3 contains 6 is_associated_with::transmembrane domains, a pore-forming region, and intracellular N- and C- termini and is readily blocked by is_associated_with::apamin. The gene for KCa2.3, KCNN3, is located on is_associated_with::chromosome 1q21.

Expression
KCa2.3 is found in the is_associated_with::central nervous system (CNS), is_associated_with::muscle, is_associated_with::liver, is_associated_with::pituitary, is_associated_with::prostate, is_associated_with::kidney, is_associated_with::pancreas and is_associated_with::vascular is_associated_with::endothelium tissues. KCa2.3 is most abundant in regions of the is_associated_with::brain, but has also been found to be expressed in significant levels in many other peripheral tissues, particularly those rich in is_associated_with::smooth muscle, including the is_associated_with::rectum, corpus cavernosum, colon, is_associated_with::small intestine and is_associated_with::myometrium.

The expression level of KCNN3 is dependent on hormonal regulation, particularly by the is_associated_with::sex hormone is_associated_with::estrogen. Estrogen not only enhances transcription of the KCNN3 gene, but also affects the activity of KCa2.3 channels on the is_associated_with::cell membrane. In is_associated_with::GABAergic is_associated_with::preoptic area neurons, estrogen enhanced the ability of α1 adrenergic receptors to inhibit KCa2.3 activity, increasing cell excitability. Links between hormonal regulation of is_associated_with::sex organ function and KCa2.3 expression have been established. The expression of KCa2.3 in the corpus cavernosum in patients undergoing estrogen treatment as part of is_associated_with::gender reassignment surgery was found to be increased up to 5-fold. The influence of estrogen on KCa2.3 has also been established in the is_associated_with::hypothalamus, uterine and is_associated_with::skeletal muscle.

Physiology
KCa2.3 channels play a major role in human physiology, particularly in is_associated_with::smooth muscle relaxation. The expression level of KCa2.3 channels in the is_associated_with::endothelium influences arterial tone by setting arterial smooth muscle is_associated_with::membrane potential. The sustained activity of KCa2.3 channels induces a sustained hyperpolarisation of the endothelial cell membrane potential, which is then carried to nearby smooth muscle through gap junctions. Blocking the KCa2.3 channel or suppressing KCa2.3 expression causes a greatly increased tone in resistance arteries, producing an increase in peripheral resistance and is_associated_with::blood pressure.

Pathology
is_associated_with::Mutations in KCa2.3 are suspected to be a possible underlying cause for several is_associated_with::neurological disorders, including is_associated_with::schizophrenia, is_associated_with::bipolar disorder, is_associated_with::Alzheimer's disease, is_associated_with::anorexia nervosa and is_associated_with::ataxia  as well as is_associated_with::myotonic muscular dystrophy.